Wenzhou Kangning Hospital Co., Ltd.

SEHK:2120 Stock Report

Market Cap: HK$894.7m

Wenzhou Kangning Hospital Past Earnings Performance

Past criteria checks 2/6

Wenzhou Kangning Hospital's earnings have been declining at an average annual rate of -9%, while the Healthcare industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 15.3% per year. Wenzhou Kangning Hospital's return on equity is 5.8%, and it has net margins of 5.6%.

Key information

-9.0%

Earnings growth rate

-9.6%

EPS growth rate

Healthcare Industry Growth11.3%
Revenue growth rate15.3%
Return on equity5.8%
Net Margin5.6%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Wenzhou Kangning Hospital Co., Ltd.'s (HKG:2120) Share Price Matching Investor Opinion

Sep 26
Wenzhou Kangning Hospital Co., Ltd.'s (HKG:2120) Share Price Matching Investor Opinion

We Think The Compensation For Wenzhou Kangning Hospital Co., Ltd.'s (HKG:2120) CEO Looks About Right

May 23
We Think The Compensation For Wenzhou Kangning Hospital Co., Ltd.'s (HKG:2120) CEO Looks About Right

Estimating The Fair Value Of Wenzhou Kangning Hospital Co., Ltd. (HKG:2120)

Feb 28
Estimating The Fair Value Of Wenzhou Kangning Hospital Co., Ltd. (HKG:2120)

Investors Continue Waiting On Sidelines For Wenzhou Kangning Hospital Co., Ltd. (HKG:2120)

Jan 19
Investors Continue Waiting On Sidelines For Wenzhou Kangning Hospital Co., Ltd. (HKG:2120)

Wenzhou Kangning Hospital (HKG:2120) Has A Somewhat Strained Balance Sheet

Nov 23
Wenzhou Kangning Hospital (HKG:2120) Has A Somewhat Strained Balance Sheet

Wenzhou Kangning Hospital (HKG:2120) Could Be Struggling To Allocate Capital

Jun 16
Wenzhou Kangning Hospital (HKG:2120) Could Be Struggling To Allocate Capital

Returns Are Gaining Momentum At Wenzhou Kangning Hospital (HKG:2120)

Mar 23
Returns Are Gaining Momentum At Wenzhou Kangning Hospital (HKG:2120)

Is Wenzhou Kangning Hospital (HKG:2120) Using Too Much Debt?

Dec 06
Is Wenzhou Kangning Hospital (HKG:2120) Using Too Much Debt?

Returns On Capital Are Showing Encouraging Signs At Wenzhou Kangning Hospital (HKG:2120)

Aug 11
Returns On Capital Are Showing Encouraging Signs At Wenzhou Kangning Hospital (HKG:2120)

Calculating The Fair Value Of Wenzhou Kangning Hospital Co., Ltd. (HKG:2120)

Jul 09
Calculating The Fair Value Of Wenzhou Kangning Hospital Co., Ltd. (HKG:2120)

Wenzhou Kangning Hospital (HKG:2120) Is Experiencing Growth In Returns On Capital

May 12
Wenzhou Kangning Hospital (HKG:2120) Is Experiencing Growth In Returns On Capital

Wenzhou Kangning Hospital (HKG:2120) Has A Pretty Healthy Balance Sheet

Apr 10
Wenzhou Kangning Hospital (HKG:2120) Has A Pretty Healthy Balance Sheet

Wenzhou Kangning Hospital Co., Ltd.'s (HKG:2120) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Feb 25
Wenzhou Kangning Hospital Co., Ltd.'s (HKG:2120) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Will Wenzhou Kangning Hospital (HKG:2120) Multiply In Value Going Forward?

Jan 17
Will Wenzhou Kangning Hospital (HKG:2120) Multiply In Value Going Forward?

Should You Use Wenzhou Kangning Hospital's (HKG:2120) Statutory Earnings To Analyse It?

Dec 23
Should You Use Wenzhou Kangning Hospital's (HKG:2120) Statutory Earnings To Analyse It?

If You Had Bought Wenzhou Kangning Hospital's (HKG:2120) Shares Five Years Ago You Would Be Down 42%

Dec 10
If You Had Bought Wenzhou Kangning Hospital's (HKG:2120) Shares Five Years Ago You Would Be Down 42%

Can Mixed Fundamentals Have A Negative Impact on Wenzhou Kangning Hospital Co., Ltd. (HKG:2120) Current Share Price Momentum?

Nov 27
Can Mixed Fundamentals Have A Negative Impact on Wenzhou Kangning Hospital Co., Ltd. (HKG:2120) Current Share Price Momentum?

Revenue & Expenses Breakdown

How Wenzhou Kangning Hospital makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SEHK:2120 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 241,6479322535
31 Mar 241,6228922534
31 Dec 231,5968622532
30 Sep 231,5603322933
30 Jun 231,525-1923333
31 Mar 231,505-2222833
31 Dec 221,485-2422433
30 Sep 221,4561221332
30 Jun 221,4284820331
31 Mar 221,3634619230
31 Dec 211,2974418228
30 Sep 211,2074515529
30 Jun 211,1325413930
31 Mar 211,0605513626
31 Dec 209895613321
30 Sep 209684914814
30 Jun 20947421626
31 Mar 20904491576
31 Dec 19861571526
30 Sep 19814741397
30 Jun 19768911268
31 Mar 19757861247
31 Dec 18746811226
30 Sep 18743731234
30 Jun 18740651232
31 Mar 18703571152
31 Dec 17666491072
30 Sep 1758858921
30 Jun 1750967770
31 Mar 1746268770
31 Dec 1641569770
30 Sep 1639462790
30 Jun 1637355810
31 Mar 1635855730
31 Dec 1534456640
30 Sep 1533256590
30 Jun 1531956530
31 Mar 1530854500
31 Dec 1429651480
31 Dec 1322636390

Quality Earnings: 2120 has high quality earnings.

Growing Profit Margin: 2120 became profitable in the past.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 2120's earnings have declined by 9% per year over the past 5 years.

Accelerating Growth: 2120 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 2120 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (-16.9%).

Return on Equity

High ROE: 2120's Return on Equity (5.8%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/29 15:26
End of Day Share Price 2024/12/27 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Wenzhou Kangning Hospital Co., Ltd. is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ruili BianCitigroup Inc
Ying ShaoCLSA
Sze Chuen TamCore Pacific -Yamaichi International (H.K.) Limited